Related Experiment Video

Updated: Jan 6, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.9K

Comparative efficacy and safety of chlorthalidone and hydrochlorothiazide-meta-analysis

Stela Dineva1, Katya Uzunova2, Velichka Pavlova2

  • 1Science Department, Tchaikapharma High Quality Medicines, Inc, 1 G.M. Dimitrov Blvd, 1172, Sofia, Bulgaria. s.dineva.hq@tchaikapharma.com.

Journal of Human Hypertension
|October 10, 2019
PubMed

Insights

Chlorthalidone (CTLD) slightly outperforms hydrochlorothiazide (HCTZ) in controlling hypertension, demonstrating superior blood pressure reduction. Both drugs show similar safety profiles, but more research is needed on their effects on serum electrolytes.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Research

Background:

  • Hypertension is a complex condition requiring effective treatment to reduce cardiovascular risks.
  • Hydrochlorothiazide (HCTZ) and chlorthalidone (CTLD) are established antihypertensive medications.
  • Optimizing therapy is crucial for managing high blood pressure and associated morbidity/mortality.

Purpose of the Study:

  • To compare the efficacy of HCTZ and CTLD in patients with hypertension.
  • To evaluate the blood pressure-lowering effects of HCTZ versus CTLD.
  • To assess the safety profiles of HCTZ and CTLD in hypertension management.

Main Methods:

  • A systematic meta-analysis was conducted, searching major electronic databases.
  • Nine randomized trials directly comparing HCTZ and CTLD were included.
  • Random-effects models and forest plots were used for analysis, with sensitivity analyses performed.

Main Results:

  • CTLD showed a statistically significant superiority over HCTZ in reducing systolic blood pressure (SBP) by -3.26 mmHg (95% CI).
  • CTLD also demonstrated a statistically significant advantage in reducing diastolic blood pressure (DBP) by -2.41 mmHg (95% CI).
  • Limited data were available regarding the effects of both drugs on serum potassium and sodium levels.

Conclusions:

  • Chlorthalidone (CTLD) exhibits a slight superiority in blood pressure control compared to hydrochlorothiazide (HCTZ).
  • The safety profiles of HCTZ and CTLD appear comparable based on the available data.
  • Further research is recommended to elucidate the differential effects of CTLD and HCTZ on serum electrolytes.

More Related Videos

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.1K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.1K

Related Concept Videos

Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
1.5K
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
541
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
867
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
760
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.2K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.2K